Home Online Features Oxford Brain Diagnostics has been granted FDA Clearance for its novel MRI Software - CDM Insights, marking a key advancement in assessing neurodegeneration for patients
Oxford Brain Diagnostics has been granted FDA Clearance for its novel MRI Software – CDM Insights, marking a key advancement in assessing neurodegeneration for patients
Press Releases
Oxford Brain Diagnostics  
January 16, 2025

Oxford Brain Diagnostics has been granted FDA Clearance for its novel MRI Software – CDM Insights, marking a key advancement in assessing neurodegeneration for patients

OXFORD, England, Jan. 16, 2025 /PRNewswire/ -- Oxford Brain Diagnostics is proud to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for CDM Insights. Powered

logo salamanca press

Salamanca Press

email salamanca press
Local & Social